Related Experiment Videos
Evidence for multiple lytic pathways used by cytotoxic T lymphocytes
1Department of Biology, University of California, Los Angeles 90024.
Journal of Immunology (Baltimore, Md. : 1950)
|October 1, 1989
Summary
Cytotoxic T-lymphocyte (CTL) mediated cytotoxicity involves distinct lysis pathways. Researchers identified three pathways, with two not relying on degranulation, challenging previous assumptions.
Area of Science:
- Immunology
- Cellular Biology
Background:
- Previous research questioned the role of degranulation in cytotoxic T-lymphocyte (CTL) mediated cytotoxicity.
- This study provides a deeper investigation into CTL lysis mechanisms.
Purpose of the Study:
- To elucidate the distinct pathways utilized by CTLs for target cell lysis.
- To investigate the role of degranulation, calcium (Ca2+), and protein kinase C (PKC) activity in CTL-mediated cytotoxicity.
Main Methods:
- CTL-mediated lysis was analyzed using three inhibitors: 4,4'-diisothiocyano-2,2'-disulfonic acid stilbene, EGTA (to chelate Ca2+), and prolonged PMA exposure to exhaust PKC.
- The dependence of lysis pathways on Ca2+, PMA sensitivity, degranulation, and protein synthesis was assessed.
Main Results:
- Three distinct CTL lysis pathways were identified: Pathway I (Ca2+-dependent, PMA-sensitive, degranulation-independent), Pathway II (Ca2+-independent, PMA-insensitive, degranulation-independent), and a third pathway involving degranulation observed in some CTL clones.
- Pathway I is the primary mechanism for most target cells, while Pathway II is induced by specific target cells, leading to the apparent shutdown of Pathway I.
- Pathway II does not require protein synthesis and results in target cell DNA solubilization.
Conclusions:
- CTLs employ multiple, distinct pathways for target cell lysis, with degranulation not being a universal requirement.
- The induction of a Ca2+-independent lysis pathway (Pathway II) highlights the adaptability of CTLs in targeting specific cells.
- A subset of CTLs utilizes a degranulation-dependent pathway, potentially influenced by interleukin-2 (IL-2) levels.